Reirradiation for locally recurrent breast cancer

Imagem de Miniatura
Arquivos
art_MARTA_Reirradiation_for_locally_recurrent_breast_cancer_2017.PDF (274.34 KB)
Citações na Scopus
15
Tipo de produção
article
Data de publicação
2017
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
CHURCHILL LIVINGSTONE
Autores
HIJAL, Tarek
Citação
BREAST, v.33, p.159-165, 2017
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The aim of this study is to review the current status of reirradiation therapy (Re-RT) for locally recurrent breast cancer. The overall outcome of breast/chest wall Re-RT is difficult to assess because of the wide range of different treatments that a patient may have undergone and the patient's individual features. The local control and complete response rates were reported to be 43-96% and 41-71%, respectively. The combination of Re-RT and hyperthermia seems to be related to improved outcomes. Toxicity rates vary between studies, and Re-RT is generally well tolerated. Re-RT may be considered an option for patients with breast cancer relapse after prior irradiation. Further studies are needed to determine the best irradiation volume and treatment modality for patients with locally recurrent disease.
Palavras-chave
Breast cancer, Radiation therapy, Recurrence, Treatment, Reirradiation
URI
https://observatorio.fm.usp.br/handle/OPI/21288
Referências
  1. Alpert TE, 2005, INT J RADIAT ONCOL, V63, P845, DOI 10.1016/jijrobp.2005.02.035
  2. Andre F, 2004, J CLIN ONCOL, V22, P3302, DOI 10.1200/JCO.2004.08.095
  3. BECK TM, 1983, J CLIN ONCOL, V1, P400
  4. BEDWINEK JM, 1981, CANCER, V47, P2232, DOI 10.1002/1097-0142(19810501)47:9<2232::AID-CNCR2820470921>3.0.CO;2-R
  5. Burger AEE, 2013, BREAST J, V19, P310, DOI 10.1111/tbj.12105
  6. Chadha M, 2008, BRACHYTHERAPY, V7, P22, DOI 10.1016/j.brachy.2007.10.006
  7. Chen L, 2014, BREAST CANCER RES TR, V147, P609, DOI 10.1007/s10549-014-3112-6
  8. DAHLSTROM KK, 1993, CANCER, V72, P774, DOI 10.1002/1097-0142(19930801)72:3<774::AID-CNCR2820720323>3.0.CO;2-Y
  9. Datta NR, 2016, INT J RADIAT ONCOL, V94, P1073, DOI 10.1016/j.ijrobp.2015.12.361
  10. Deutsch M, 2002, INT J RADIAT ONCOL, V53, P687, DOI 10.1016/S0360-3016(02)02785-2
  11. Doyle T, 2001, INT J RADIAT ONCOL, V51, P74, DOI 10.1016/S0360-3016(01)01625-X
  12. DRAGOVIC J, 1989, J CLIN ONCOL, V7, P30
  13. FOURQUET A, 1989, INT J RADIAT ONCOL, V17, P719
  14. FOWBLE B, 1990, INT J RADIAT ONCOL, V19, P833
  15. Giordano SH, 2004, CANCER, V100, P44, DOI 10.1002/cncr.11859
  16. Hannoun-Levi JM, 2013, RADIOTHER ONCOL, V108, P226, DOI 10.1016/j.radonc.2013.03.026
  17. Hannoun-Levi JM, 2004, INT J RADIAT ONCOL, V60, P1385, DOI 10.1016/j.ijrobp.2004.05.035
  18. Harms W, 2001, INT J RADIAT ONCOL, V49, P205, DOI 10.1016/S0360-3016(00)01360-2
  19. Harms W, 2016, STRAHLENTHER ONKOL, V192, P199, DOI 10.1007/s00066-015-0939-7
  20. Huston TL, 2005, AM J SURG, V189, P229, DOI 10.1016/j.amsurg.2004.07.039
  21. Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107
  22. Kauer-Dorner D, 2012, RADIOTHER ONCOL, V102, P96, DOI 10.1016/j.radonc.2011.07.020
  23. Kesson EM, 2012, BMJ-BRIT MED J, V344, pe2718, DOI 10.1136/BMJ.E2718
  24. KURTZ JM, 1991, EUR J CANCER, V27, P240, DOI 10.1016/0277-5379(91)90505-8
  25. Li Gong, 2004, Int J Clin Oncol, V9, P179
  26. Linthorst M, 2015, RADIOTHER ONCOL, V117, P217, DOI 10.1016/j.radonc.2015.04.019
  27. Linthorst M, 2013, RADIOTHER ONCOL, V109, P188, DOI 10.1016/j.radonc.2013.05.010
  28. Marta GN, 1992, REV ASSOC MED BRAS, V2014, P508
  29. Marta GN, 2011, REV ASSOC MED BRAS, V57, P468, DOI 10.1590/S0104-42302011000400024
  30. Mauro GP, 2016, BREAST, V28, P73, DOI 10.1016/j.breast.2016.05.001
  31. MCCREADY DR, 1992, CAN J SURG, V35, P485
  32. Merino T, 2015, ONCOTARGET, V6, P35051, DOI 10.18632/oncotarget.6036
  33. Niehoff P, 2006, STRAHLENTHER ONKOL, V182, P102, DOI 10.1007/s00066-006-1496-x
  34. Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738
  35. Oldenborg S, 2016, STRAHLENTHER ONKOL, V192, P240, DOI 10.1007/s00066-016-0946-3
  36. Oldenborg S, 2015, RADIOTHER ONCOL, V117, P223, DOI 10.1016/j.radonc.2015.10.017
  37. OSBORNE MP, 1994, WORLD J SURG, V18, P93
  38. Panet-Raymond V, 2011, INT J RADIAT ONCOL, V81, P409, DOI 10.1016/j.ijrobp.2010.05.063
  39. PHROMRATANAPONGSE P, 1991, Strahlentherapie und Onkologie, V167, P93
  40. Salvadori B, 1999, BRIT J SURG, V86, P84
  41. Sedlmayer F, 2013, BREAST, V22, pS141, DOI 10.1016/j.breast.2013.07.026
  42. Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166
  43. Trombetta M, 2009, AM J CLIN ONCOL-CANC, V32, P314, DOI 10.1097/COC.0b013e31818af0b9
  44. van der Zee J, 1999, BRIT J CANCER, V79, P483
  45. Vernon CC, 1996, INT J RADIAT ONCOL, V35, P731
  46. Voogd AC, 2005, EUR J CANCER, V41, P2637, DOI 10.1016/j.ejca.2005.04.040
  47. Wahl AO, 2008, INT J RADIAT ONCOL, V70, P477, DOI 10.1016/j.ijrobp.2007.06.035

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - ODS/03